Abstract Body

Background: Despite the ability of antiretroviral therapy to suppress viral replication, proviral HIV-1 persists in resting memory CD4+ T cells. These cells, termed the latent reservoir, represent a major barrier to HIV-1 eradication. One strategy to purge this reservoir, termed “shock and kill”, aims to induce proviral transcription without inducing cellular activation (the “shock”) with subsequent elimination of these cells via viral cytopathic effect or immune system targeting (the “kill”). While a number of promising candidate “shock” compounds have been identified, ongoing research suggests that “shocked” T cells do not undergo cell death. Novel strategies to eliminate these cells may be necessary for the “shock and kill” approach to deplete the latent reservoir. We hypothesize that resting central memory CD4+ T cells (Tcm) expressing HIV-1 genes are phenotypically distinct from their uninfected and latently infected counterparts and can be selectively targeted for apoptosis. Methodology: We designed an in vitro screening assay to evaluate for selective apoptosis induction among Tcm actively expressing HIV-1 genes. Naïve CD4+ T cells from healthy donors were activated by T cell receptor stimulation and progressed to a quiescent state determined by morphology and loss of activation markers. 10 days post-activation they were infected with eGFP-pseudotyped HIV-1. Screening was performed with a chemical compound library containing 160 cell-permeable protein kinase inhibitors. Apoptosis among infected (GFP+) and uninfected (GFP-) cells was detected by flow cytometry. Screening hits were defined as compounds that induced apoptosis among GFP+ cells greater than three standard deviations (SD) above the apoptosis mean from negative control wells. Compounds inducing apoptosis >3SD above baseline in both GFP+ and GFP- cells were excluded as non-specific. Results: We identified two kinase inhibitors, HA1077 and kenpaullone, that reproducibly and selectively target HIV-1 infected resting Tcm for apoptosis in independent experiments using cells from multiple donors. HA1077 is a Rho kinase inhibitor and kenpaullone is an inhibitor of multiple cyclin-dependent kinases and glycogen synthase kinase 3α and β. These compounds appear to be non-toxic and trigger minimal bystander cell apoptosis. Conclusions: We have developed a novel primary cell screening assay to identify compounds that selectively induce apoptosis in HIV-1 infected resting Tcm. Using a commercial kinase inhibitor library we have identified two reproducible compound hits to date. These compounds, and the mechanisms by which they selectively induce apoptosis in HIV-1 infected cells, merit further exploration. These results may help to further ongoing HIV-1 eradication strategies.